Evidence map›Paper›PMID 30918010›Full record

ArticleLife science alliance2019

A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis.

Peter Ac Wing, Tamara Davenne, Jochen Wettengel, Alvina G Lai, Xiaodong Zhuang, Anindita Chakraborty, Valentina D'Arienzo, Catharina Kramer, Chunkyu Ko, James M Harris and 8 more

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. NTCP ubiquitination enables HBV infection.JHEP reports : innovation in hepatology · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Mitosis of hepatitis B virus-infected cellsJHEP reports : innovation in hepatology · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Peter Ac WingNuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0002-2354-3281
Tamara DavenneMedical Research Council Human Immunology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Jochen WettengelInstitute of Virology, Technische Universität München/Helmholtz Zentrum München, Munich, Germany.
Alvina G LaiNuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0001-8960-8095
Xiaodong ZhuangNuffield Department of Medicine, University of Oxford, Oxford, UK.
Anindita ChakrabortyInstitute of Virology, Technische Universität München/Helmholtz Zentrum München, Munich, Germany.
Valentina D'ArienzoNuffield Department of Medicine, University of Oxford, Oxford, UK.
Catharina KramerNuffield Department of Medicine, University of Oxford, Oxford, UK.
Chunkyu KoInstitute of Virology, Technische Universität München/Helmholtz Zentrum München, Munich, Germany.
James M HarrisNuffield Department of Medicine, University of Oxford, Oxford, UK.
Sabrina SchreinerInstitute of Virology, Technische Universität München/Helmholtz Zentrum München, Munich, Germany.
Martin HiggsInstitutes of Cancer and Genomic Sciences and Immunity and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, UK.ORCID 0000-0002-8218-0089
Stephanie RoesslerInstitute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0002-5333-5942
Joanna L ParishInstitutes of Cancer and Genomic Sciences and Immunity and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, UK.ORCID 0000-0002-7111-4211
Ulrike ProtzerInstitute of Virology, Technische Universität München/Helmholtz Zentrum München, Munich, Germany.ORCID 0000-0002-9421-1911
Peter BalfeInstitutes of Cancer and Genomic Sciences and Immunity and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, UK.ORCID 0000-0002-6246-0876
Jan RehwinkelMedical Research Council Human Immunology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0003-3841-835X
Jane A McKeatingNuffield Department of Medicine, University of Oxford, Oxford, UK jane.mckeating@ndm.ox.ac.uk.ORCID 0000-0002-7229-5886
University of Oxford · GBHelmholtz Zentrum München · DEUniversity of Birmingham · GBHeidelberg University · DE

Funding

Medical Research Council G0400802Medical Research Council G0801976Medical Research Council G0902418Medical Research Council G1100247Medical Research Council MC_UU_00008/8Medical Research Council MR/N023498/1Medical Research Council MR/P009085/1Medical Research Council MR/R022011/1Wellcome Trust
6 · The paper itself

Abstract

Chronic hepatitis B is one of the world's unconquered diseases with more than 240 million infected subjects at risk of developing liver disease and hepatocellular carcinoma. Hepatitis B virus reverse transcribes pre-genomic RNA to relaxed circular DNA (rcDNA) that comprises the infectious particle. To establish infection of a naïve target cell, the newly imported rcDNA is repaired by host enzymes to generate covalently closed circular DNA (cccDNA), which forms the transcriptional template for viral replication. SAMHD1 is a component of the innate immune system that regulates deoxyribonucleoside triphosphate levels required for host and viral DNA synthesis. Here, we show a positive role for SAMHD1 in regulating cccDNA formation, where KO of SAMHD1 significantly reduces cccDNA levels that was reversed by expressing wild-type but not a mutated SAMHD1 lacking the nuclear localization signal. The limited pool of cccDNA in infected

Indexed as

DNA, CircularDNA, ViralGene Knockout TechniquesHepatitis B, ChronicHepatitis B virusHep G2 CellsHumansReverse TranscriptionRNA-Directed DNA PolymeraseSAM Domain and HD Domain-Containing Protein 1Transcriptional ActivationTransfectionVirus ReplicationDNA, CircularDNA, ViralRNA-Directed DNA PolymeraseSAM Domain and HD Domain-Containing Protein 1SAMHD1 protein, human

Identifiers

PMID30918010
PMCPMC6438393
OpenAlexW2929034931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.